Data are already available that show that expression profiling can be used to distinguish cell type-specific gene clusters (stromal, epithelial, mesenchymal and proliferation status) and to classify breast tumors as basal-like, luminal-like, ERBB2 overexpressing and normal breast-like. The gene discussed is ERBB2; the disease is breast neoplasm.